cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.
Company profile
Ticker
CAH
Exchange
Website
CEO
Michael Kaufmann
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CARDINAL DISTRIBUTION INC
SEC CIK
Corporate docs
Subsidiaries
A+ Secure Packaging, LLC • Aero-Med, LLC • Allegiance Corporation • Cardinal Health 2, LLC • Cardinal Health 3, LLC • Cardinal Health 5, LLC • Cardinal Health 6, Inc. • Cardinal Health 7, LLC • Cardinal Health 100, LLC • Cardinal Health 104 LP ...
IRS number
310958666
CAH stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
16 Nov 23
10-Q
2024 Q1
Quarterly report
3 Nov 23
8-K
Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
3 Nov 23
DEFA14A
Additional proxy soliciting materials
12 Oct 23
DEFA14A
Additional proxy soliciting materials
10 Oct 23
ARS
2023 FY
Annual report to shareholders
27 Sep 23
DEFA14A
Additional proxy soliciting materials
27 Sep 23
DEF 14A
Definitive proxy
27 Sep 23
8-K
Entry into a Material Definitive Agreement
6 Sep 23
10-K
2023 FY
Annual report
15 Aug 23
Transcripts
CAH
Earnings call transcript
2024 Q1
3 Nov 23
CAH
Earnings call transcript
2023 Q4
15 Aug 23
CAH
Earnings call transcript
2023 Q3
4 May 23
CAH
Earnings call transcript
2023 Q2
2 Feb 23
CAH
Earnings call transcript
2023 Q1
4 Nov 22
CAH
Earnings call transcript
2022 Q4
11 Aug 22
CAH
Earnings call transcript
2022 Q3
5 May 22
CAH
Earnings call transcript
2022 Q2
3 Feb 22
CAH
Earnings call transcript
2022 Q1
9 Nov 21
CAH
Earnings call transcript
2021 Q4
5 Aug 21
Latest ownership filings
4
DEBORAH WEITZMAN
29 Nov 23
144
Notice of proposed sale of securities
27 Nov 23
4
Jessica L Mayer
16 Nov 23
4
Michelle Brennan
16 Nov 23
4
Steven Barg
16 Nov 23
4
Patricia Hemingway Hall
16 Nov 23
4
Sujatha Chandrasekaran
16 Nov 23
4
CHRISTINE MUNDKUR
16 Nov 23
4
Nancy Killefer
16 Nov 23
4
AKHIL JOHRI
16 Nov 23
Financial summary
| Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 3.85 bn | 3.85 bn | 3.85 bn | 3.85 bn | 3.85 bn | 3.85 bn |
| Cash burn (monthly) | 63.00 mm | (no burn) | 8.67 mm | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 136.12 mm | n/a | 18.73 mm | n/a | n/a | n/a |
| Cash remaining | 3.72 bn | n/a | 3.84 bn | n/a | n/a | n/a |
| Runway (months of cash) | 59.0 | n/a | 442.5 | n/a | n/a | n/a |
Institutional ownership, Q3 2023
85.0% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 914 |
| Opened positions | 88 |
| Closed positions | 82 |
| Increased positions | 301 |
| Reduced positions | 372 |
| 13F shares | Current |
|---|---|
| Total value | 18.17 tn |
| Total shares | 209.55 mm |
| Total puts | 1.98 mm |
| Total calls | 2.54 mm |
| Total put/call ratio | 0.8 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 32.09 mm | $2.79 tn |
| BLK Blackrock | 28.03 mm | $2.43 tn |
| STT State Street | 14.64 mm | $1.27 tn |
| FMR | 5.97 mm | $518.37 bn |
| Arrowstreet Capital, Limited Partnership | 5.80 mm | $504.42 bn |
| Geode Capital Management | 5.49 mm | $475.63 bn |
| MS Morgan Stanley | 4.42 mm | $383.44 bn |
| AMP Ameriprise Financial | 4.13 mm | $358.39 bn |
| IVZ Invesco | 3.47 mm | $301.10 bn |
| NTRS Northern Trust | 3.34 mm | $290.03 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Nov 23 | Deborah Weitzman | Common Shares | Sell | Dispose S | No | Yes | 106.31 | 36,642 | 3.90 mm | 35,202 |
| 27 Nov 23 | Deborah Weitzman | Common Shares | Option exercise | Acquire M | No | Yes | 66.43 | 15,373 | 1.02 mm | 71,844 |
| 27 Nov 23 | Deborah Weitzman | Common Shares | Option exercise | Acquire M | No | Yes | 83.19 | 6,279 | 522.35 k | 56,471 |
| 27 Nov 23 | Deborah Weitzman | Common Shares | Option exercise | Acquire M | No | Yes | 84.27 | 5,990 | 504.78 k | 50,192 |
| 27 Nov 23 | Deborah Weitzman | Employee Stock Option Common Shares | Option exercise | Dispose M | No | No | 66.43 | 15,373 | 1.02 mm | 0 |
| 27 Nov 23 | Deborah Weitzman | Employee Stock Option Common Shares | Option exercise | Dispose M | No | No | 83.19 | 6,279 | 522.35 k | 0 |
| 27 Nov 23 | Deborah Weitzman | Employee Stock Option Common Shares | Option exercise | Dispose M | No | No | 84.27 | 5,990 | 504.78 k | 0 |
| 15 Nov 23 | Edison Sheri H. | Common Shares | Grant | Acquire A | No | No | 0 | 1,965 | 0.00 | 12,051 |
| 15 Nov 23 | Evans David C | Common Shares | Grant | Acquire A | No | No | 0 | 1,965 | 0.00 | 12,576 |
| 15 Nov 23 | Kenny Gregory B | Common Shares | Grant | Acquire A | No | No | 0 | 3,193 | 0.00 | 59,680 |
News
Becton Dickinson Recalls Certain Infusion Pumps, Citing Issues With Cardinal Health's Syringes
4 Dec 23
How Is The Market Feeling About Cardinal Health?
4 Dec 23
Jim Cramer Bullish On Boeing In Latest 'Lightning Round': 'This Is Their Year'
28 Nov 23
FDA Alerting Health Care Providers & Facilities Not To Use Cardinal Health Monoject Syringes With Syringe Pumps & Patient-Controlled Analgesia Pumps; FDA Says You May Continue To Use Covidien Monoject Syringes With Syringe Pumps Or PCA Pumps
20 Nov 23
JP Morgan Maintains Neutral Rating for Cardinal Health: Here's What You Need To Know
17 Nov 23
Press releases
Cardinal Health Board of Directors Approves Quarterly Dividend
14 Nov 23
Negative Pressure Wound Therapy Systems Market Expected to Witness Massive Growth with a Significant CAGR of 5.09%, asserts DelveInsight | Companies – Medtronic, Nihon Kohden Corporation, NuVasive
10 Nov 23
Global Sterilisation Monitoring Technologies Market Projected to Reach US$1.1 Billion by 2033
31 Oct 23
Blood Thawing System Market Exceeding US$ 350M Valuation by 2031
31 Oct 23
Chlorhexidine Gluconate (CHG) Wipes Market Set to Expand at 4% CAGR
26 Oct 23